Interleukin-10 Induces Expression of Neuroendocrine Markers and PDL1 in Prostate Cancer Cells
Interleukin-10 (IL10) is best studied for its inhibitory action on immune cells and ability to suppress an antitumour immune response. But IL10 also exerts direct effects on nonimmune cells such as prostate cancer epithelial cells. Elevated serum levels of IL10 observed in prostate and other cancer...
Saved in:
| Main Authors: | Abrar Samiea, Jeff S. J. Yoon, Christopher J. Ong, Amina Zoubeidi, Thomas C. Chamberlain, Alice L.-F. Mui |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2020-01-01
|
| Series: | Prostate Cancer |
| Online Access: | http://dx.doi.org/10.1155/2020/5305306 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Effective therapeutic targeting of tumor lineage plasticity in neuroendocrine prostate cancer by BRD4 inhibitors
by: Xiong Zhang, et al.
Published: (2025-03-01) -
Cross-sectional analysis of blood leukocyte responsiveness to interleukin-10 and interleukin-6 across age and physical activity level
by: Islam Hashim, et al.
Published: (2024-11-01) -
The Androgen Receptor Bridges Stem Cell-Associated Signaling Nodes in Prostate Stem Cells
by: Alastair H. Davies, et al.
Published: (2016-01-01) -
Neuroendocrine differentiation in prostate cancer
by: Cerović Snežana J., et al.
Published: (2004-01-01) -
The regulation of miR-155 strand selection by CELF2, FUBP1 and KSRP proteins
by: Jeff S. J. Yoon, et al.
Published: (2025-08-01)